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Abstract:
Evidence for associations between Mediterranean diet (MD) during 
pregnancy and childhood asthma, allergy and related outcomes is 
conflicting. Few cohorts have followed children to school age, and none 
have considered lung function. 
In the Avon Longitudinal Study of Parents and Children, we analysed 
associations between maternal MD score during pregnancy (estimated by 
a food frequency questionnaire, using an a priori defined score adapted 
to pregnant women; score ranging from 0: low adherence to 7: high 
adherence) and current doctor-diagnosed asthma, wheeze, eczema, hay 
fever, atopy, and lung function in 8,907 children at 7-9 years and - for a 
subset - at 15 years. Interaction between maternal MD and maternal 
smoking in pregnancy was investigated. 
Weak positive associations were found between maternal MD score and 
childhood maximal mid-expiratory flow (FEF25-75). Higher MD scores 
were associated with increased z-scores adjusted for age, height and 
gender (β: 0.06 (0.01, 0.12), P= 0.03). The maternal MD score was not 
associated with asthma or allergy. The relation between MD score and 
childhood FEF25-75 at 15 years had similar effect estimates but, given 
the loss to follow up, associations were less precise. Stratifying 
associations by maternal smoking during pregnancy showed that 
associations with FEF25-75 were only seen in children of never/passive 
smoking mothers, but no evidence for a statistically significant 
interaction was found. 
Results suggest adherence to a MD during pregnancy may be associated 
with increased small airway function in childhood but we found no 
evidence for a reduced risk of asthma or allergy. 
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Evidence for associations between Mediterranean diet (MD) during pregnancy and childhood 
asthma, allergy and related outcomes is conflicting. Few cohorts have followed children to 
school age, and none have considered lung function. 
In the Avon Longitudinal Study of Parents and Children, we analysed associations between 
maternal MD score during pregnancy (estimated by a food frequency questionnaire, using an 
a priori defined score adapted to pregnant women; score ranging from 0: low adherence to 7: 
high adherence) and current doctor-diagnosed asthma, wheeze, eczema, hay fever, atopy, and 
lung function in 8,907 children at 7-9 years and - for a subset - at 15 years. Interaction 
between maternal MD and maternal smoking in pregnancy was investigated.
Weak positive associations were found between maternal MD score and childhood maximal 
mid-expiratory flow (FEF25-75). Higher MD scores were associated with increased z-scores 
adjusted for age, height and gender (β: 0.06 (0.01, 0.12), P= 0.03). The maternal MD score 
was not associated with asthma or allergy. The relation between MD score and childhood 
FEF25-75 at 15 years had similar effect estimates but, given the loss to follow up, associations 
were less precise. Stratifying associations by maternal smoking during pregnancy showed 
that associations with FEF25-75 were only seen in children of never/passive smoking mothers, 
but no evidence for a statistically significant interaction was found. 
Results suggest adherence to a MD during pregnancy may be associated with increased small 
airway function in childhood but we found no evidence for a reduced risk of asthma or 
allergy. 
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Given substantial evidence implicating the prenatal environment in the aetiology of 
childhood asthma[1], with risk factors including low birth weight[2] and maternal obesity[3], 
many observational studies have investigated the relation between maternal intake of 
individual nutrients or foods in pregnancy and the risk of asthma and other allergic outcomes 
in the offspring. Recent systematic reviews concluded that evidence from these studies was 
not consistent[4, 5]. Whilst recent randomised controlled trials (RCTs) have suggested that 
supplementation with vitamin D or fish oil in pregnancy may prevent wheezing in early 
childhood[6, 7], longer follow-up is needed to determine whether these interventions can 
prevent childhood asthma. Very few studies have investigated the relation between prenatal 
nutrition and childhood lung function, although we recently reported weak evidence  
suggesting that lower prenatal iron and zinc status might be associated with lower lung 
function in children[8, 9]. The paucity of such studies is perhaps surprising, given that low 
birth weight has been linked to lower childhood lung function[10], early childhood wheezing 
is associated with later lung function abnormalities[11], and lung function shortly after birth 
is associated with childhood asthma[12]. 
An alternative, but less adopted, approach to investigating the role of maternal diet in 
pregnancy is to study broader aspects of the diet by defining dietary patterns, which might 
take into account the inter-correlations and biological interactions that occur between 
individual foods or nutrients. A Mediterranean diet (MD) is typified by a high intake of 
vegetables, legumes, fruits and nuts, unrefined cereals, fish and olive oil, a low-to-moderate 
intake of dairy products, and a low intake of meat and poultry and saturated fats[13]. Given 
that low birthweight, prematurity and gestational weight gain are risk factors for childhood 
asthma[2, 3, 14], and low birthweight and premature birth are also risk factors for lower 
childhood lung function [10, 15], high adherence to a MD in pregnancy might be expected to 






























































protect against asthma and/or impaired lung function in the offspring; in a birth cohort study, 
low adherence to a Mediterranean-like diet in pregnancy was associated with lower birth 
weight[16], and a recent RCT found that a MD intervention (with additional extra virgin 
olive oil and pistachio nuts) reduced the rate of small for gestational age newborns, 
prematurity and gestational weight gain[17]. It also reduced gestational diabetes[17], which 
has been associated with an increased risk of atopic eczema and atopy in one observational 
study[18]. A number of observational studies have investigated whether adherence to a MD 
in pregnancy might protect against the development of asthma and allergies in the offspring, 
and a recent systematic review concluded that there was some evidence that higher adherence 
was associated with a lower risk of wheezing in infancy, but evidence for a lower risk of 
asthma, wheezing and atopic outcomes later in childhood was lacking [19]. However, only 
one prospective study followed the children to school age [20] and none examined 
associations with lung function. As a MD is rich in antioxidants, we might expect any 
beneficial effects of a MD on childhood outcomes to be greatest amongst offspring of 
mothers who smoked in pregnancy, since tobacco smoke is a source of oxidative stress [21], 
and that high adherence to a MD would attenuate the detrimental effects of maternal 
smoking.
In a large UK population-based birth cohort, we have investigated whether greater adherence 
to a MD in pregnancy is associated with a reduced risk of asthma and other atopic outcomes 
and with higher lung function in the offspring at school age. 
































































The Avon Longitudinal Study of Parents and Children (ALSPAC) is a population-based birth 
cohort that recruited 14,541 predominantly white pregnant women resident in Avon, UK with 
expected dates of delivery 1st April 1991 to 31st December 1992. These pregnancies resulted 
in 13,972 singleton or twin children who were alive at one year of age. The cohort has been 
followed since birth with annual questionnaires and, since age 7 years, with objective 
measures in annual research clinics. The study protocol has been described previously [22, 
23]. Please note that the study website contains details of all the data that are available 
through a fully searchable data dictionary and variable search tool: 
http://www.bristol.ac.uk/alspac/researchers/our-data/. Ethics approval was obtained from the 
ALSPAC Ethics and Law Committee (IRB 00003312) and the Local NHS Research Ethics 
Committees. Informed consent for the use of data collected via questionnaires and clinics was 
obtained from participants following the recommendations of the ALSPAC Ethics and Law 
Committee at the time.
Exposure assessment
Data on maternal diet in pregnancy were collected by a food frequency questionnaire (FFQ) 
at 32 weeks gestation, covering all the main foods consumed in Britain at the time [24]. This 
FFQ has been shown to produce mean nutrient intakes for the mothers [24] which were 
similar to those obtained for women in the British National Diet and Nutritional survey for 
adults [25, 26]. 






























































The questionnaire asked about current weekly frequency of consumption of 43 food groups 
and food items, with the possibility for respondents to tick one of the following options: 
never or rarely, once in 2 weeks, 1-3 times a week, 4-7 times a week, more than once a day.
More detailed questions were asked about daily consumption of a further eight basic foods 
(including sugar, coffee and tea). The FFQ was used to estimate total energy intake and daily 
nutrient intake, by multiplying the daily frequency of consumption of a food by the nutrient 
content[27] of a standard portion[28] of that food, and summing this for all the foods 
consumed. Information on portion size was not collected. In order to apply quantitative 
meaning to the frequency categories, the data were numerically transformed into times per 
week as follows: i) 0; ii) 0.5; iii) 2; iv) 5.5 and v) 10 times per week. The number of slices of 
bread consumed each day on average was recorded separately and the amount of milk 
consumed was estimated from the number of cups of white tea/coffee consumed per day and 
the frequency of breakfast cereal, milky puddings and milk drinks consumed per week. 
A MD score was based on that devised by Chatzi et al [20] for pregnant women, 
which was adapted from the original MD score by Trichopoulou et al [13]. Chatzi et al 
included dairy products as beneficial rather than detrimental and did not include alcohol. The 
score is based on the median weekly intake of six beneficial food groups (vegetables, 
legumes, fruits/nuts, cereal, fish and dairy) and one detrimental food group (meat) [See online 
supplement Table S1] for a detailed description of the food groups from the FFQ contributing 
to each component of the score and median weekly consumption]. Women whose 
consumption of the beneficial food groups was above the median were assigned a value of 1 
and those below were assigned a value of 0. Conversely, for the detrimental food group, 
consumption below the median was assigned a value of 1 and above the median was assigned 
a value of 0. The seven food group values were then summed together to obtain a score which 






























































ranged from 0 to 7, with a higher score representing greater adherence to a Mediterranean-
style diet. 
Outcome assessment
Current doctor-diagnosed asthma was defined in children at 7.5 years (primary 
outcome) if mothers responded positively to the question ‘Has a doctor ever actually said that 
your study child has asthma?’ and to one or both of the questions ‘Has your child had any of 
the following in the past 12 months: wheezing with whistling; asthma?. 
Current wheezing, eczema and hay fever in children at 7.5 years were defined by a positive 
answer to the question: ‘Has your child had any of the following in the past 12 months: 
wheezing with whistling; eczema; hay fever?’. 
Atopy at 7 years was defined as a positive reaction (maximum diameter of any detectable 
weal) to D.pteronyssinus, cat or grass (after subtracting positive saline reactions from 
histamine and allergen weals, and excluding children unreactive to 1% histamine). 
Lung function was measured by spirometry (Vitalograph 2120) at age 8½ years after 
withholding short-acting bronchodilators for at least 6 hours and long-acting bronchodilators 
and theophyllines for at least 24 hours. The best of three reproducible flow-volume curves 
was used to measure forced expiratory volume in 1 second (FEV1), forced vital capacity 
(FVC) and maximal mid-expiratory flow (FEF25-75), which were further transformed to age, 
height and gender adjusted standard deviation units[29]. The tests adhered to American 
Thoracic Society (ATS) criteria for standardisation and reproducibility of flow-volume 
measurement[30], with the exception of ATS recommendations for duration of 
expiration[31]; as many children did not fulfil forced expiratory time >6 seconds end of test 
criteria, a minimal volume change over the final 1 second was used. Lung function was also 
measured at 15 years.































































We selected potential confounding factors which are known (from existing literature) 
to be associated with one or more of the outcomes of interest[32]. These included maternal 
age at delivery, sex of child, multiple pregnancy, season of birth, maternal history of atopic 
diseases (hay fever, asthma, eczema, allergies, or attacks of wheezing with whistling on the 
chest or attacks of breathlessness in the past two years), parity, highest educational 
qualification in UK schools (Certificate of Secondary Education, Vocational, Ordinary level, 
Advanced level, Degree), housing tenure, financial difficulties, ethnicity, breastfeeding 
duration, and maternal factors during pregnancy (smoking status, anxiety score [Crown-Crisp 
Experiential Index][33], paracetamol use, antibiotic use, infections [urinary infection, 
influenza, rubella, thrush, genital herpes, other], supplement use and total energy intake 
[kJ/day]). Smoking status was categorised as the maximum exposure during pregnancy 
(never, passive smoking only, 1-9 cigarettes per day, 10-19 cigarettes per day, 20 cigarettes 
per day). 
Statistical analyses
We compared the distributions of child and maternal variables across the maternal MD 
score categories (≥ 4 versus ≤ 3, as done previously by Chatzi el al [20]) using t-tests for 
differences in continuous variables and chi-squared tests for differences in categorical 
variables. Logistic regression, multinomial logistic regression, and linear regression were 
used to analyse relations between the maternal MD score in pregnancy and binary, 
categorical and continuous outcomes, respectively. We analysed the maternal MD score first 
as a binary variable (i.e. ≥ 4 and ≤ 3; [20]) using the lower category as reference, and second 
as a continuous variable to test for linear trend (i.e. per increasing score-unit effect). For all 






























































regression analyses, two stages of adjustment were used. In Model 1 we adjusted for total 
energy intake only. In Model 2 we adjusted additionally for all potential confounders listed 
above. 
When evidence for associations persisted, we considered other factors which could be 
considered either as potential confounders or potential mediators of associations between 
maternal MD in pregnancy and childhood outcomes, namely, prematurity [14, 15, 17], 
impaired fetal growth[2, 10, 16, 17], maternal obesity and weight gain [3, 17] and offspring 
obesity[34, 35]. We therefore adjusted additionally for maternal pre-pregnancy body mass 
index (BMI) (self-reported), gestational age at delivery, birth weight, maternal weight gain 
during pregnancy (all abstracted from obstetric records) and child’s BMI at 7 (based on 
measured height and weight at clinic) (See online Figure S1 in the online supplement 
showing a directed acyclic graph). As a MD is rich in antioxidants, we might expect any 
beneficial effects on childhood outcomes to be greatest amongst offspring of mothers who 
smoked in pregnancy, since tobacco smoke is a source of oxidative stress[21]. We therefore 
stratified the dietary analyses by maternal smoking history (dichotomised) to explore 
potential effect modification by smoking and tested for interaction. We also explored whether 
the association between maternal smoking in pregnancy and FEF25-75, previously reported in 
ALSPAC [36], was modified by MD score (dichotomised). 
As sensitivity analyses, we repeated analyses after exclusion of mothers with 
implausible energy intakes (<2,500 or >25,000 kJ/day[37]). To correct for potential loss to 
follow-up bias, we used inverse probability weighting and assigned to each woman a weight 
that is the inverse of the probability of her selection for given values of covariates (see further 
details online) [38]. All statistical analyses were carried out using Stata version 12.1 
(StataCorp LP, USA). 































































Of the 13,972 singleton or twin children alive at one year of age, information on 
maternal diet was available for 11,993, of whom there was information on at least one of the 
outcomes of interest for 8,907 (online Figure S2). Characteristics of the 8,907 mother-child 
pairs who were included in the analyses, and those of the 3,086 mother-child pairs with 
information on maternal diet who were excluded because of incomplete outcome data, are 
compared in online Table S2. 
Women in the higher category of MD score during pregnancy were older and more 
educated than women in the lower category. They were more likely to give birth in winter or 
spring, to breastfeed for 3 months or longer, to be better educated, to have an 
owned/mortgaged house and to use supplements during pregnancy. They were less likely to 
have financial difficulties, to have a high anxiety score, to smoke or to use paracetamol 
during pregnancy. They also had a lower pre-pregnancy BMI, higher total energy intake, and 
gained more weight during pregnancy. Their offspring were more likely to have weighed 
more at birth and less likely to have a high BMI at 7 (Table 1).  
After controlling for confounders, maternal MD score (whether analysed as a binary 
or continuous variable), was not associated with asthma, wheeze, eczema, hayfever or atopy 
(Table 2). When we analysed the associations between the maternal MD score and childhood 
lung function at 8-9 years after controlling for total energy intake only, strong evidence was 
found for positive associations with childhood FEV1 and FEF25-75. These associations slightly 
weakened after further adjustment for potential confounders, but evidence for a positive 
association with childhood FEF25-75 persisted when comparing higher versus lower maternal 
MD score (difference in age, height and gender adjusted standard deviation units: 0.06 (95% 
CI: 0.01, 0.12), P-value: 0.03) (Table 3). When we analysed the relation between MD score 
and childhood lung function at 15 years, the per-unit increase effect estimates for FEF25-75 






























































were similar to those observed at 8 years (online Table S3); however given the smaller 
sample size, associations were no longer conventionally significant,
Additional separate adjustment for maternal pre-pregnancy BMI, gestational age at 
delivery, birth weight, maternal weight gain during pregnancy and child’s BMI at 7 did not 
alter the main findings (data not shown) and therefore no further formal mediation analysis 
was conducted. Excluding mothers with implausible energy intakes did not alter the main 
findings, nor did the inverse probability weighting analysis (data not shown).
When we stratified the analyses of MD and lung function by maternal smoking in pregnancy, 
maternal MD was positively associated with childhood FEF25-75 amongst non/passive 
smokers, but not amongst active smokers, but no evidence for a statistically significant 
interaction was found (Table 4). Conversely, when we stratified the negative association 
between maternal smoking in pregnancy and FEF25-75 by MD score (dichotomised), there was 
no evidence of attenuation of the association by higher adherence to a MD (data not shown).































































This is the largest observational study to investigate the relation between MD in 
pregnancy and childhood respiratory and allergic outcomes.  A limitation of the evidence to 
date is that many studies have assessed maternal diet retrospectively or have only 
investigated outcomes in infancy. Of two cohort studies which assessed MD during 
pregnancy and outcomes beyond infancy, one from Spain (n=460) reported significant 
negative associations with wheeze and atopy at 6.5 years [20], another larger study from the 
US (n=1,376) found no association with asthma, wheeze or atopy at 3 years [39]. Given the 
much larger size of ALSPAC, and our null findings for childhood asthma, wheeze and 
allergic outcomes, we would argue that the weight of current prospective evidence suggests 
that adherence to a MD in pregnancy is unlikely to reduce the risk of these conditions at 
school age. However, we found weak evidence that a higher MD score during pregnancy was 
associated with higher FEF25-75 in the offspring, after controlling for potential confounders. 
Previous studies have not investigated the relation between MD in pregnancy and childhood 
lung function; to the best of our knowledge this is a novel finding. 
Mechanisms
If the association between MD in pregnancy and lung function in the offspring is causal, one 
plausible explanation is that it is mediated through the high antioxidant content of the fruit, 
vegetables and cereals in a MD [19]. If this were the case we would have expected to see an 
interaction between maternal MD score in pregnancy and maternal smoking on childhood 
FEF25-75. To our knowledge, this has not been investigated before. We hypothesized a priori 
that a higher MD score in pregnancy might be particularly beneficial if the fetus was exposed 
to tobacco smoke, by protecting the developing lung from potentially damaging oxidative 
stress[21]. In fact, there was no association between a MD in pregnancy and lung function 
amongst active smokers. On the contrary, an association was only seen amongst mothers who 






























































had not actively smoked in pregnancy. An alternative, post hoc, hypothesis could be that 
benefits are only seen above a certain threshold of adherence to a MD, and we have 
confirmed that mothers who did not actively smoke in pregnancy had a higher MD score than 
those who did. We also found no evidence that the detrimental effects of maternal smoking 
on childhood FEF25-75 were attenuated by higher adherence to a MD. Apart from its 
antioxidant properties, a MD may also have anti-inflammatory effects [40]. Part of this effect 
may reflect the anti-inflammatory properties of omega-3 PUFAs in oily fish. We speculate 
that this might partly explain the association between a MD in pregnancy and offspring lung 
function that we observed; a recent trial reported that fish oil-derived omega-3 fatty acid 
supplementation in pregnancy reduced the risk of early childhood wheezing in the offspring 
[7], and early childhood wheezing is associated with later reductions in lung function [11]. 
We found no evidence to suggest that the association between maternal MD score and 
childhood FEF25-75 was mediated by maternal BMI, gestational weight gain or child’s BMI, 
nor by prematurity or low birthweight.
Strengths and limitations
Strengths of the ALSPAC birth cohort include its population-based prospective 
design, rich information on numerous potential confounders, detailed phenotypic outcome 
measurements, and its size, which gave us greater statistical power than the previous birth  
cohort study that has investigated this research question in offspring of school age[20].
The MD score has been developed in Mediterranean countries and is based on 
population-specific median values. Thus it may not be adapted to non-Mediterranean 
countries such as the UK, in which median intakes of some specific foods may be lower, and 
potential beneficial effects might be missed. However, the fact that similar results were 
observed when the MD score was studied as a binary (above versus below median) or as a 






























































continuous variable makes this possibility less likely. A previous study of maternal dietary 
patterns in pregnancy in relation to childhood respiratory outcomes has been conducted in 
ALSPAC, using principal component analysis (PCA) to derive dietary patterns [41]. That 
study showed that dietary patterns in pregnancy, including a ‘health conscious’ pattern 
(which had some similarities to a MD), did not predict asthma and related outcomes in the 
offspring after controlling for confounders. However, data-driven methods such as PCA are 
population-specific, and using a priori approaches such as the MD score is more relevant in 
terms of public health. Other a priori approaches such as the Alternate Healthy Eating Index 
(AHEI) score, which is based on international guidelines and has been adapted for pregnant 
women (AHEI-P) [42], may be more adapted to non-Mediterranean populations; however 
given the lack of information on some specific AHEI-P food/nutrient items in ALSPAC’s 
FFQ (eg. trans-fat), it was not applicable in ALSPAC pregnant women.
Although the FFQ that we used had not been formally calibrated against other instruments 
such as diet diaries, it was based on the one used by Yarnell et al which has been validated 
against weighed dietary records [43], and modified in the light of a more recent weighed 
dietary survey [24]. Whilst there might have been some misclassification of dietary exposures 
(eg. bread consumption was assessed differently compared to other food groups, and thus 
may have been overestimated), this is likely to have been non-differential with respect to the 
outcomes of interest, and would be expected to bias effect estimates towards the null; in other 
words, the magnitude of associations may have been underestimated, and small or modest 
effects may have been missed. The possibility that the association between MD in pregnancy 
and offspring lung function might be explained by uncontrolled or residual confounding 
cannot be ruled out, especially given that the MD score is highly correlated with social and 
lifestyle factors. However, we think that this is unlikely, as we controlled for numerous 
potential confounders in the analyses.  As with any longitudinal study, we cannot rule out the 






























































possibility that exclusion of mother-child pairs without complete information might have 
biased our findings. However, it could be argued that, for our results to be totally spurious for 
the MD score and childhood lung function in those included in our analysis (and for the 
associations to be truly null in the population as a whole), associations in the excluded 
mother-child pairs would have to be at least of equal magnitude in the opposite direction, 
which seems unlikely. Furthermore, loss to follow-up bias has been shown to only slightly 
modify associations in longitudinal studies, including in ALSPAC [44], and the results of our 
inverse probability weighting analysis confirmed that loss to follow-up is unlikely to have 
biased our results. In view of the multiple analyses carried out, we cannot exclude the 
possibility that the associations between MD in pregnancy and offspring lung function 
occurred by chance; hence they should be interpreted with caution and require replication in 
another birth cohort study. Given the a priori nature of the general hypothesis being tested 
(ie. beneficial effect of a MD), and the fact that some outcomes of interest were highly 
correlated, it did not seem appropriate to correct for multiple testing.
 
Conclusions 
We found weak evidence that greater adherence to a MD in pregnancy is associated 
with higher small airway function in the offspring. Further studies in school-aged children are 
needed to confirm these results. 
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Table 1. Characteristics of mothers and offspring who had information on at least one of the 
outcomes of interest (wheeze, asthma, atopy, eczema, hayfever, total IgE, lung function) by 
maternal Mediterranean diet score in pregnancy (n=8,907)
Mediterranean diet score





























































Mother’s educational level, %


































































































Yes 19.8 15.4 <.001
Maternal history of atopic diseases, %
Yes 69.1 67.9 0.24































Maternal paracetamol use during pregnancy, %
Yes 64.6 61.0 0.001
Maternal antibiotic use during pregnancy, %
Yes 16.0 16.2 0.81




Maternal infections in pregnancy, %
Yes 45.1 46.2 0.33
Total energy intake (kcal/day), m (sd) 1600 (451) 1826 (459) <.001































Gestational age (weeks), m (sd) 39.4 (1.8) 39.5 (1.8) 0.13


























































































*Chi-squared tests were used for categorical variables, and t-tests were used for continuous 
variables.






























































Table 2. Associations between maternal Mediterranean diet score during pregnancy and 
asthma, wheeze, eczema, hay fever and atopy in the offspring (n=8, 629)
 OR: Odds ratio
a Controlling for energy intake 
b Controlling for energy intake, smoking, infections, supplements, antibiotics and 
paracetamol use during pregnancy; maternal educational level, housing tenure, financial 
difficulties, ethnicity, age, parity, history of atopic diseases, anxiety; sex of child, season of 
birth, multiple pregnancy, breastfeeding duration
Mediterranean diet score
4-7 versus 0-3 P-value Per unit increase P-trend
Asthma (n=7,634)
ORa (95% CI) 0.94 (0.81, 1.09) 0.41 0.97 (0.92, 1.01) 0.15
ORb (95% CI) 1.03 (0.88, 1.20) 0.71 1.00 (0.95, 1.05) 0.93
Wheeze (n=7,719)
ORa (95% CI) 1.02 (0.88, 1.19) 0.80 1.01 (0.96, 1.06) 0.84
ORb (95% CI) 1.04 (0.89, 1.22) 0.62 1.01 (0.96, 1.07) 0.63
Eczema (n=7,705)
ORa (95% CI) 1.13 (0.99, 1.29) 0.07 1.03 (0.99, 1.07) 0.18
ORb (95% CI) 1.10 (0.96, 1.26) 0.18 1.01 (0.97, 1.06) 0.55
Hay fever (n=7,685)
ORa (95% CI) 1.00 (0.85, 1.18) 0.99 1.01 (0.96, 1.07) 0.72
ORb (95% CI) 0.97 (0.81, 1.15) 0.69 1.00 (0.94, 1.06) 0.97
Atopy (n=6,078)
ORa (95% CI) 1.03 (0.90, 1.17) 0.66 1.03 (0.98, 1.07) 0.23
ORb (95% CI) 0.94 (0.82, 1.07) 0.34 0.99 (0.95, 1.04) 0.81






























































Table 3. Associations between maternal Mediterranean diet score during pregnancy (binary 
and continuous) and FEV1, FVC and FEF25-75 in the offspring (n=6,120)
GMR: geometric mean ratio; β: difference in age, height and gender adjusted standard 
deviation units 
a Controlling for energy intake 
b Controlling for energy intake, smoking, infections, supplements, antibiotics and paracetamol 
use during pregnancy; maternal educational level, housing tenure, financial difficulties, 
ethnicity, age, parity, maternal history of atopic diseases, anxiety score; sex of child, season 
of birth, multiple pregnancy, breastfeeding duration
Mediterranean diet score
4-7 versus 0-3 P-value Per unit increase P-trend
FEV1 (n=6,026)
β a (95% CI) 0.07 (0.01, 0.12) 0.01 0.03 (0.01, 0.04) 0.005
β b (95% CI) 0.05 (-0.01, 0.10) 0.11 0.02 (0.00, 0.04) 0.06
FVC (n=6,120)
β a (95% CI) 0.03 (-0.03, 0.08) 0.36 0.01 (0.00, 0.03) 0.12
β b (95% CI) 0.01 (-0.05, 0.06) 0.78 0.01 (-0.01, 0.03) 0.38
FEF25-75 (n=6,120)
β a (95% CI) 0.08 (0.02, 0.13) 0.005 0.02 (0.01, 0.04) 0.01
β b (95% CI) 0.06 (0.01, 0.12) 0.03 0.02 (0.00, 0.04) 0.06






























































Table 4. Associations between maternal Mediterranean diet score during pregnancy and 
childhood lung function stratified by maternal smoking during pregnancy (n=6,115)
β: difference in age, height and gender adjusted standard deviation units 
* Controlling for energy intake, infections, supplements, antibiotics and paracetamol use 
during pregnancy; maternal educational level, housing tenure, financial difficulties, ethnicity, 
age, parity, maternal history of atopic diseases, anxiety score; sex of child, season of birth, 
multiple pregnancy, breastfeeding duration
 a treating smoking as a binary variable and the Mediterranean diet score as either a binary or 
continuous variable
Mediterranean diet score,  β* (95% CI)
4-7 versus 0-3 P-value Per unit increase P-trend
FEV1 
    Non/passive smokers (n=4,479) 0.05 (-0.02, 0.11) 0.15 0.02 (0.00, 0.04) 0.10
   Active smokers (n=1,542) 0.04 (-0.07, 0.15) 0.45 0.02 (-0.02, 0.06) 0.29
P interaction a 0.81 0.96
FVC 
    Non/passive smokers (n=4,558) 0.01 (-0.05, 0.08) 0.71 0.01 (-0.02, 0.03) 0.59
   Active smokers (n=1,557) 0.01 (-0.09, 0.12) 0.80 0.02 (-0.02, 0.05) 0.33
P interaction a 0.69 0.90
FEF25-75 
    Non/passive smokers (n=4,558) 0.07 (0.00, 0.13) 0.04 0.02 (0.00, 0.04) 0.05
   Active smokers (n=1,557) 0.04 (-0.07, 0.15) 0.44 0.01 (-0.03, 0.04) 0.70
P interaction a 0.86 0.68































































Please find enclosed our paper entitled “Mediterranean diet during pregnancy and 
childhood respiratory and atopic outcomes: birth cohort study”. 
Evidence for associations between a maternal Mediterranean diet (MD) during 
pregnancy and childhood asthma, allergy and related outcomes is conflicting, with few 
longitudinal studies following children to school age, and none have considered lung 
function. We have investigated the associations between maternal MD in pregnancy and 
childhood atopic and respiratory outcomes at school age, in the large UK population-based 
birth cohort ALSPAC (The Avon Longitudinal Study of Parents and Children). We have 
found evidence suggesting adherence to a MD during pregnancy may be associated with 
increased small airway function in childhood but, contrary to some previous smaller studies, 
we found no evidence for a reduced risk of asthma or allergy. Given the size of our study, we 
believe it represents an important contribution to the literature on maternal diet in pregnancy 
and childhood atopy and respiratory health. We hope that this paper will be of interest to the 
ERJ readership.  
This manuscript is not published or submitted for publication elsewhere and all the 
authors have read it, agreed that this work is ready for submission and have accepted the 
responsibility for its content.
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Inverse probability weighting has been proposed as a way to correct for selection bias [1].  
By assigning to each subject a weight that is the inverse of the probability of his/her selection 
based on a given set of covariates and exposure, inverse probability weighting creates a 
pseudo-population in which effect measures are not affected by selection bias (provided that 
the outcome in the uncensored subjects truly represents the outcome in the censored subjects 
for the same values of covariates and exposure). We used this approach by estimating for 
each woman, the probability of her selection for given values of covariates (ie. the 
characteristics for which differences between excluded and included women were found to be 
statistically significant, including the exposure – see online Table 1) and assigning her a 
weight that is the inverse of that probability. 
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Online Table S1: Food groups from the FFQ contributing to the Mediterranean score 
calculation and estimated median weekly consumption.
MD Component Food groups from FFQ1 Median weekly 
consumption


































Dairy Milk3 6553.3g 50.1%
1 frequency of consumption of these food groups were summed together to obtain an overall 
‘weekly consumption’ for each component
2 Bread consumption was recorded as the number of slices consumed per day. This was 
multiplied by 7, to obtain weekly consumption.
3 Milk consumption estimated based on responses to questions asking the mother about how 
often she consumed milk as a drink on it’s own, milky drinks and milky puddings. This data 
was combined with milk consumption through tea, coffee and cereal. As these could not all 






























































be readily converted into a frequency of consumption we estimated actual consumption in 
grams. 






























































Online Table S2. Characteristics of mothers and offspring who were included in analyses 
and those who were excluded (n=11,993)
Included  (n=8,907) Excluded (n=3,086) P
Maternal Mediterranean diet score, m (sd) 3.9 (1.5) 3.5 (1.5) < .001
























































Mother’s educational level, %




































Yes 17.1 22.9 < .001
Maternal history of atopic diseases, %






























































Yes 68.4 68.9 0.63



































Maternal antibiotic use during pregnancy, %
Yes 16.1 14.6 0.04
Maternal supplement use during pregnancy, %
Yes 56.8 58.9 0.05
Maternal infections in pregnancy, %
Yes 45.8 46.9 0.28
Total energy intake (kJ/day), m (sd) 7271 (1962) 7174 (2147) 0.02































Gestational age (weeks), m (sd) 39.5 (1.8) 39.4 (1.8) 0.06














Maternal weight gain during pregnancy, %









































































































































Online Table S3. Associations between maternal Mediterranean diet score during pregnancy 
(binary and continuous) and lung function at 15 years (n=3,549)
β: difference in age, height and gender adjusted standard deviation units 
a Controlling for energy intake 
b Controlling for energy intake, smoking, infections, supplements, antibiotics and 
paracetamol use during pregnancy; maternal educational level, housing tenure, financial 
difficulties, ethnicity, age, parity, maternal history of atopic diseases, anxiety score; sex of 
child, season of birth, multiple pregnancy, breastfeeding duration
Mediterranean diet score
4-7 versus 0-3 P-value Per unit increase P-trend
FEV1 (n=3,404)
β a (95% CI) 0.04 (-0.03, 0.11) 0.31 0.01 (-0.01, 0.04) 0.33
β b (95% CI) 0.04 (-0.03, 0.12) 0.27 0.02 (-0.01, 0.04) 0.23
FVC (n=3,549)
β a (95% CI) 0.02 (-0.06, 0.09) 0.67 0.01 (-0.02, 0.03) 0.51
β b (95% CI) 0.02 (-0.05, 0.10) 0.54 0.01 (-0.01, 0.04) 0.32
FEF25-75 (n=3,549)
β a (95% CI) 0.05 (-0.02, 0.12) 0.20 0.02 (0.00, 0.05) 0.06
β b (95% CI) 0.04 (-0.04, 0.11) 0.32 0.02 (0.00, 0.04) 0.10






























































Online Figure S1. Directed acyclic graph showing potential confounders and mediators of 
the associations between maternal Mediterranean diet score in pregnancy and offspring 
respiratory and atopic outcomes     






























































Online Figure S2. Participant flow






























































STROBE Statement—Checklist of items that should be included in reports of cohort studies 
Item 
No Recommendation
(a) Indicate the study’s design with a commonly used term in the title or the abstract Title and abstract 1
(b) Provide in the abstract an informative and balanced summary of what was done 
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection
(a) Give the eligibility criteria, and the sources and methods of selection of 
participants. Describe methods of follow-up
Participants 6
(b) For matched studies, give matching criteria and number of exposed and 
unexposed
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable
Data sources/ 
measurement
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if there is 
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why
(a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, explain how loss to follow-up was addressed
Statistical methods 12
(e) Describe any sensitivity analyses
Results
(a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
Participants 13*
(c) Consider use of a flow diagram
(a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
Descriptive data 14*
(c) Summarise follow-up time (eg, average and total amount)
Outcome data 15* Report numbers of outcome events or summary measures over time
(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and 
their precision (eg, 95% confidence interval). Make clear which confounders were 
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
Main results 16
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period






























































Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses
Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based
*Give information separately for exposed and unexposed groups.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and 
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely 
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
available at http://www.strobe-statement.org.
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